Wettig Thane (CIK 1815638) reported 13 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-09). Recent activity: Sell KYNB (198 shares), Buy KYNB (2,800 shares), Sell KYNB (2,800 shares), Sell KYNB (277 shares), Sell FGEN (259 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-09 | KYNTRA BIO, INC. (KYNB) | CEO | Sell | 198 | $1,329 |
| 2026-05-19 | KYNTRA BIO, INC. (KYNB) | CEO | Buy | 2,800 | $19,852 |
| 2026-05-18 | KYNTRA BIO, INC. (KYNB) | CEO | Sell | 2,800 | $19,852 |
| 2026-03-10 | KYNTRA BIO, INC. (KYNB) | CEO | Sell | 277 | $1,895 |
| 2025-12-09 | FIBROGEN INC (FGEN) | CEO | Sell | 259 | $2,181 |
| 2025-11-17 | FIBROGEN INC (FGEN) | CEO | Buy | 1,000 | $9,180 |
| 2025-11-17 | FIBROGEN INC (FGEN) | CEO | Buy | 2,700 | $24,570 |
| 2025-09-09 | FIBROGEN INC (FGEN) | CEO | Sell | 246 | $1,926 |
| 2025-09-09 | FIBROGEN INC (FGEN) | CEO | Sell | 248 | $3,001 |
| 2025-03-25 | FIBROGEN INC (FGEN) | CEO | Buy | 145,000 | $50,750 |
| 2025-03-07 | FIBROGEN INC (FGEN) | CEO | Sell | 22,038 | $8,595 |
| 2025-03-07 | FIBROGEN INC (FGEN) | CEO | Buy | 781 | $0 |
| 2025-03-07 | FIBROGEN INC (FGEN) | CEO | Sell | 367 | $143 |
Source: SEC Form 4 filings · as of 2026-06-09